A Phase Ii, Multicenter, Open-Label Study Of Polypepi1018 In Combination With Atezolizumab In Participants With Relapsed Or Refractory Microsatellite-Stable Metastatic Colorectal (Mss Mcrc) Cancer (Oberto-301): Initial Results
Atezolizumab;POLYPEPI-1018
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A Phase Ii, Multicenter, Open-Label Study Of Polypepi1018 In Combination With Atezolizumab In Participants With Relapsed Or Refractory Microsatellite-Stable Metastatic Colorectal (Mss Mcrc) Cancer (Oberto-301): Initial Results ### Output: Atezolizumab;POLYPEPI-1018